Mechanisms of Treatment Change in Panic Disorder and Agoraphobia
Panic Disorder With Agoraphobia
About this trial
This is an interventional treatment trial for Panic Disorder With Agoraphobia focused on measuring Respiration panic, Cognitions, Panic, Treatment, Mediators, Moderators
Eligibility Criteria
Inclusion Criteria:
- A current DSM-IV diagnosis of panic disorder with agoraphobia that is designated by the patient as the most important source of current distress
- Patients must be willing to engage in exposure to fearful situations and sensations
Exclusion Criteria:
- A history of bipolar disorder, psychosis or delusional disorders, current substance abuse or dependence
Medical Exclusion Factors:
- Patients with severe unstable medical illness, or serious medical illness for which hospitalization may be likely within the next three months
- Patients with a history of seizures, angina, myocardial infarction, congestive heart failure, clinically significant arrhythmias, transient ischemic attacks, cerebrovascular accidents, diabetes mellitus, significant asthma, emphysema, or chronic obstructive pulmonary disease
Sites / Locations
- Southern Methodist University, Department of Psychology
Arms of the Study
Arm 1
Arm 2
Arm 3
Active Comparator
Active Comparator
Other
Cognitive Therapy
Capnometry-Assisted Respiratory Training
In-vivo exposure therapy
The training included four components: (a) educating patients about exacerbating panic symptoms through catastrophic thoughts (vicious cycle), (b) identifying negative cognitions associated with physical sensation triggers of recent panic attacks, (c) practicing replacement of maladaptive cognitions with non catastrophic explanations, and (d) instructing patients in between session exercises during Phase I.
The training included four components: (a) educating patients about the exacerbation of panic symptoms through hypocapnia; (b) directing patients' attention to potentially detrimental respiratory patterns; (c) teaching patients techniques to control their respiration, in particular end-tidal PCO2; and (d) instructing patients in between-session exercises. Between-session exercises using a portable capnometer were to be performed twice a day for 17 min at home or elsewhere during Phase I.
In this two-phase intervention, patients were randomized (within each site) to first receive five individual, weekly, 1-hr sessions of respiratory skill training (CART) or cognitive skill training (CT; Phase I, Skill Acquisition Training), followed by three weekly sessions of in-vivo exposure (Phase II, Application Training) plus a fourth session at 2-month follow-up.